Philipp Gramann is the Strategy Lead in Medical Affairs at Bayer Pharmaceuticals, where they focus on combining strategic consulting with digital transformation initiatives. Previously, they freelanced as a management consultant, supporting digital transformation and organizational development for large companies, primarily within the DAX 30 sector. Philipp also held various roles at Bayer, including R&D Business Program Lead and R&D Strategist. They possess a Master's degree in Business Administration from Hochschule für Wirtschaft und Recht Berlin and a Bachelor's degree in Business Administration from Duale Hochschule Baden-Württemberg.
This person is not in any teams
This person is not in any offices